XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue:        
Total revenue $ 52,483 $ 24,854 $ 104,614 $ 73,963
Operating costs and expenses:        
Cost, Product and Service [Extensible Enumeration] Product Sales [Member] Product Sales [Member] Product Sales [Member] Product Sales [Member]
Product costs $ 6,921 $ 5,141 $ 17,926 $ 14,745
Research and development 11,232 12,975 36,899 38,350
Selling, general and administrative 12,874 12,854 39,077 33,159
Acquired intangible asset amortization 879 1,024 2,659 3,184
Restructuring expense     1,282  
Contingent consideration (gain) expense (835) 3 (829) 9
Total operating costs and expenses 31,071 31,997 97,014 89,447
Operating income (loss) 21,412 (7,143) 7,600 (15,484)
Other expense:        
Interest expense, net (884) (145) (2,594) (410)
Foreign exchange (loss) gain (61) 85 (261) 120
Investment income, net 182 22 531 73
Other expense (763) (38) (2,324) (217)
Income (loss) before income taxes 20,649 (7,181) 5,276 (15,701)
Income tax (expense) benefit (13,303) 1,530 (13,506) 3,155
Net income (loss) $ 7,346 $ (5,651) $ (8,230) $ (12,546)
Basic net income (loss) per share $ 0.52 $ (0.41) $ (0.59) $ (0.90)
Diluted net income (loss) per share $ 0.52 $ (0.41) $ (0.59) $ (0.90)
Weighted average number of shares outstanding:        
Basic 14,050 13,929 14,020 13,907
Diluted 14,072 13,929 14,020 13,907
Product Sales [Member]        
Revenue:        
Total revenue $ 15,667 $ 13,919 $ 45,251 $ 40,227
Royalties and License Fees [Member]        
Revenue:        
Total revenue 34,153 8,795 52,347 26,738
Research, Development and Other [Member]        
Revenue:        
Total revenue $ 2,663 $ 2,140 $ 7,016 $ 6,998